2019 INDIANA LIFE
SEPTEMBER 26, 2019 | INDIANAPOLIS, IN
NEW LOCATION: INDIANAPOLIS MARRIOTT NORTH
Join us as we bring together speakers from around the world
and celebrate life sciences innovation at our 16th annual Summit.
THE SUMMIT INCLUDES:
Ted-like Talks by
Cook Group and Eli Lilly and
Company Networking Reception
Founder + Chief Scientific Officer
BRUCE LAMB, PhD
Stark Neurosciences Research Institute
CLEM MCDONALD, MD
Chief Health Data Standards Officer, National Library of Medicine, National Institutes of Health
LIANA G. APOSTOLOVA
MD, MSc, FAAN
School of Medicine
Founder + Chief Scientific Officer | Paige
CEO | Lighthouse3
BRUCE LAMB, MD
Director | Stark Neuroscience Center
CLEM MCDONALD, MD
MD Chief Health Data Standards Officer, National Library of Medicine, National Institutes of Health
MD, MSC, FAAN
IU School of Medicine
Click the button below to complete your registration for the 2019 Indiana Life Sciences Summit.
REFUND POLICY: Refunds for cancellation will be given up to 2 weeks prior to the event.
After September 12, 2019, we will be unable to issue refunds for any reason.
THOMAS FUCHS Founder + Chief Scientific Officer, Paige
Professor Dr. Thomas J. Fuchs is the Founder and Chief Scientific Officer at Paige, the leader in computational pathology focused on building artificial intelligence (AI) to transform the clinical diagnosis and treatment of cancer. Additionally, he is an Associate Professor for Machine Learning at Weill-Cornell University, and a director of the Warren Alpert Center for Digital and Computational Pathology at Memorial Sloan Kettering Cancer Center in New York City.
LIANA G. APOSTOLOVA, MD, MSc, FAAN The Barbara and Peer Baekgaard Professor in Alzheimer’s Disease Research and Professor in Neurology, Radiology, Medical and Molecular Genetics at the Indiana University School of Medicine
Liana G. Apostolova, joined the IU School of Medicine as a The Barbara and Peer Baekgaard Professor in Alzheimer’s Disease Research and Professor in Neurology, Radiology, Medical and Molecular Genetics at in June of 2015. Dr. Apostolova is a prolific researcher. Her research focuses on the early symptomatic and presymptomatic stages of Alzheimer’s Disease and on the development and validation of sensitive imaging and genetic biomarkers for Alzheimer’s disease and other dementing disorders. Dr. Apostolova is the recipient of many NIH and industry supported grants and several research awards. She is the principal investigator of the multimodal clinical and biomarker Longitudinal Early-Onset AD Study (LEADS, R56 and U01 AG057195) which will recruit, characterize and follow 400 patients with definite EOAD and 100 age-matched control subjects across 15 US clinical sites. She also directs the Clinical Core of the Alzheimer’s Disease Center at Indiana University. Dr. Apostolova has served as a research mentor to over 70 undergraduate, 23 graduate, and five post-graduate students, as well as nine junior faculty researchers to date. She serves as Editor for the Alzheimer’s and Dementia: Disease Assessment and Monitoring Journal. She graduated Summa Cum Laude from the Medical University, Sofia, Bulgaria in 1998, and completed Neurology residency training at University of Iowa and Dementia fellowship at UCLA.
BRUCE LAMB, Ph.D. Executive Director, Stark Neurosciences Research Institute, Roberts Family Chair in Alzheimer’s Disease Research Professor, Medical & Molecular Genetics, IU School of Medicine
Dr. Lamb received a BA degree in Biology from Swarthmore College, his PhD in Molecular Biology from the University of Pennsylvania and a post-doctoral fellowship at Johns Hopkins University. In 1996, Dr. Lamb was recruited to Case Western Reserve University, where he rose from Assistant to Associate Professor and finally moved to the Cleveland Clinic in 2005. At the Cleveland Clinic, Dr. Lamb was promoted from Associate Professor to Full Professor in 2011, and later was recruited to become the Executive Director of the Stark Neurosciences Research Institute with the IU School of Medicine in January 2016.
Dr. Lamb has received numerous awards and honors including the Jennifer B. Langston Award from the Cleveland Chapter of the Alzheimer’s Association, the National Civic Award, and the Zaven Khachaturian Lifetime Achievement Award from the National Alzheimer’s Association. He is a Fellow in the American Association for the Advancement of Science and a member (and Vice-Chair) of the Medical and Scientific Advisory Council of the National Alzheimer’s Association.
Dr. Lamb’s laboratory works on the basic science of Alzheimer’s disease, with a focus on: 1) genetic modifiers identified from both mouse and human studies, 2) microglia and neuronal-microglial communication in the development and progression of AD pathologies; and 3) traumatic brain injury as an environmental modifier for the development of AD pathologies. Dr. Lamb is also one of the lead PIs of the NIH-funded Model Organism Development and Evaluation for Late-onset Alzheimer’s Disease (MODEL-AD) consortium. In addition, Dr. Lamb is actively involved in advocacy for increased research funding for the disease.
MIA DAND CEO, Lighthouse3
Mia Dand is a digital transformation leader and passionate diversity in tech advocate with extensive experience in building human-centric programs at global companies like Google, HP, eBay, Symantec and others. As the CEO of Lighthouse3, an emerging tech research and advisory firm based in Oakland, California, Mia guides large enterprises on responsible adoption of new technologies like Artificial Intelligence with special emphasis on critical areas like ethics, governance, and regulatory compliance.
Mia is the author of “100 Brilliant Women in AI Ethics”, a definitive guide to help conference organizers and brands recruit more talented women in this space. She is also the organizer for SF AI, Berkeley AI, & SF AR/VR meetup groups with over 3.5K members in the San Francisco Bay Area and hosts monthly AI Ethics chats on Twitter (@MiaD)
CLEM MCDONALD, MD MD Chief Health Data Standards Officer, National Library of Medicine, National Institutes of Health
Dr. McDonald’s research focuses on clinical informatics; analyzing clinical data and providing feedback to clinicians; development and study of electronic medical record systems (EMRs) and personal health records (PHRs); automatic reminder systems; promoting the development, enhancement, and adoption of clinical messaging and vocabulary standards; and using huge clinical databases and de-identifying them for clinical research use.
He has led the development of the medical informatics standards necessary for transmitting patient data from source systems to electronic medical records and research databases. He was one of the founders of the Health Level 7 (HL7) message standards, used in all hospitals today, and he also developed the Logical Observation Identifier Names and Codes (LOINC) database of universal codes for clinical observations, including laboratory tests, clinical measurements and physician reports.
In 1972, Dr. McDonald developed one of the nation’s first electronic medical record systems (EMRs), the Regenstrief Medical Record System (RMRS), and directed its use in clinical trials that have illuminated the ways in which electronic records can improve patient care. He published the first randomized trials showing the benefits of computer reminder systems and of physician order entry systems. He has written more than 275 peer-reviewed articles. Additionally, he implemented the Indiana Network for Patient Care, the first community-wide health information exchange, which now carries over 4 billion clinical observations from more than 70 hospitals, and is considered a national model for regional health information exchange.
His work at NIH continues this trend. Dr. McDonald collaborates in numerous efforts to facilitate industry adoption of standard vocabularies in electronic medical records and public health reporting, as required by meaningful use regulations. He has been working with numerous NIH Institutes to align research terminology with federally mandated clinical terminologies. He emphasizes the need for using the same standards where information content overlaps between clinical and research domains (e.g. laboratory testing, vital signs, and clinical survey instruments) that can be integrated with existing clinical LOINC variables to allow data sharing and interoperability.
Dr. McDonald served as the Scientific Director of the Lister Hill National Center for Biomedical Communications at NLM from 2006-2018, overseeing all LHNCBC research and development in biomedical informatics related to consumer health, clinical data, image processing and visualization, and natural language processing. Current research projects include biomedical data visualization, high resolution electron microscopy, imaging tools for cancer research, and 3D biomedical imaging research, openI (medical citations enriched by relevant images with capacity to search by image), and automated medical text indexing research. Dr. McDonald currently serves as the NLM Chief Health Data Standards Officer.
Dr. McDonald obtained his medical degree from the University of Illinois, and completed his internship in Internal Medicine at Boston City Hospital, Harvard Medical Service, and his residency in Internal Medicine at Cook County Hospital and University of Wisconsin. Before beginning his residency, he earned an MS in Biomedical Engineering from Northwestern University, and completed a fellowship at NIH, where he managed the development of the first clinical laboratory computer system at the Clinical Research Center.
Prior to joining NLM, Dr. McDonald was Regenstrief Professor of Medical Informatics and Distinguished Professor of Medicine at the Indiana University (IU) School of Medicine and Director of the Regenstrief Institute for Health Care.